SCHEMBL29781306

SCHEMBL29781306

O=[N+]([O-])c1cc2c(O)ncnc2cc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
MAPT P10636 4/20 0.40
TDP1 Q9NUW8 3/20 0.40
KDM4E B2RXH2 3/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
IDO1 P14902 2/20 0.40
TDO2 P48775 2/20 0.40
RECQL P46063 2/20 0.40
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40
THRB P10828 1/20 0.40
PKM P14618 1/20 0.40
BLM P54132 1/20 0.40
CASP6 P55212 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
VCAM1 P19320 1/20 0.39
ATM Q13315 1/20 0.39
ABCG2 Q9UNQ0 1/20 0.38
HIF1A Q16665 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1766092 1.00 ALDH1A1 (0.40) ALDH1A1MAPTTDP1KDM4EMEN1
SCHEMBL27768928 0.83 VCAM1 (0.40) ALDH1A1MAPTTDP1KDM4EMEN1
SCHEMBL29719028 0.83 EGFR (0.41) ALDH1A1MAPTTDP1KDM4EMEN1
SCHEMBL25409 0.83 EGFR (0.41) ALDH1A1MAPTTDP1KDM4EMEN1
SCHEMBL156334 0.81 MAP4K4 (0.43) ALDH1A1MAPTTDP1VCAM1ATM
Hydrochloric Acid SCHEMBL4781507 0.81 EGFR (0.40) ALDH1A1MAPTTDP1KDM4EMEN1
SCHEMBL17538470 0.81 MAPT (0.40) ALDH1A1MAPTTDP1KDM4EMEN1
SCHEMBL30420453 0.81 MAP4K4 (0.43) ALDH1A1MAPTTDP1VCAM1ATM
SCHEMBL22983920 0.81 ABCG2 (0.38) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL16212173 0.81 EGFR (0.40) ALDH1A1MAPTTDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022170052-A1 QUINAZOLINE DERIVATIVES, PYRIDOPYRIMIDINE DERIVATIVES, PYRIMIDOPYRIMIDINE DERIVATIVES, AND USES THEREOF BLACK DIAMOND THERAPEUTICS, INC. (US) 2022-08-11 WO disclosed